JAKARTA, March 20 (dpa): Indonesia can start using 1.1 million doses of the vaccine developed by AstraZeneca, after its distribution in the country was delayed because of concerns about blood clot cases in Europe, the country's drug agency has announced.
"The benefits of giving the AstraZeneca Covid-19 vaccine outweigh the risk, so that the AstraZeneca Covid-19 vaccine can be used," the Food and Drug Control Agency said on its website.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!